Related Experiment Video
Updated: Feb 13, 2026

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes
Published on: August 20, 2007
Metformin in Diabetes Management and Immune Modulation: A Comprehensive Review
Mehrangiz Ghafari1, Javad Poursamimi2, Foroogh Asli3
1Department of Pathology, School of Medicine, Zabol University of Medical Sciences, Zabol, Iran. ghafari.mehr@yahoo.com.
Abstract:
Metformin is a primary treatment for type 2 diabetes (T2D), well-known for its ability to lower blood glucose levels through both AMP-activated protein kinase (AMPK)-dependent and -independent pathways. Recent evidence suggests that metformin also possesses immunomodulatory properties, indicating its potential as a therapeutic agent that extends beyond metabolic regulation. This review summarizes the current understanding of metformin's dual roles in managing diabetes and modulating the immune system. It also explores the underlying mechanisms, clinical implications, and potential directions for future research.
Related Concept Videos
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Review and Preview
Percentiles are a type of fractile that partition data into...
Review and Preview
What is the Immune System?
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Humoral Immune Responses

